ASCRS
MAY 2020 • VOLUME 25 • NUMBER 4
Revolution in glaucoma
medications
62
Barriers to adherence
in glaucoma medical
therapy
by Ellen Stodola
Ophthalmologists suggest
combination medications,
patient education, and drop
reminders to address some
adherence barriers.
52
Sustained-release
making inroads
in glaucoma
by Liz Hillman
Physicians discuss options for
sustained-release medications
and how these allow them to
tailor choices to meet patient
needs.
56
An overview of new
glaucoma medications
by Chiles Samaniego
Experts share details,
including mechanism of action,
efficacy, and side effects, on
three recently approved agents
for the treatment of glaucoma.
60
What constitutes
maximum medical
therapy for glaucoma?
by Vanessa Caceres
Maximum medical therapy has
evolved due to the wider array
of options available, from
different drop forms to laser
and surgical treatments.
IN FOCUS
4 | EYEWORLD | MAY 2020
